drugset / Trial / NCT05563571

Hemiplegic Shoulder Pain Management Using Shoulder pRF and Corticosteroid Injection

NCT05563571

Unknown 20 enrolled Satasairaala
RandomizedParallel-groupSingle-blindTreatment

Summary

Introduction: hemiplegic shoulder pain (HSP) in a common post-stroke condition, that can lead to poor motor and functional recovery and lower quality of life. Interventions like intra-articular corticosteroid injection (ICI) and suprascapularis nerve (SSN) pulsed radiofrecuenfy treatment (PRF) has been used to treat the pain. Methods: in this single-center, prospective, randomized controlled study, we included 20 consecutive patients with hemiplegic shoulder pain in subacute stroke phase (2-12 months after diagnosis). Subjects were randomly assigned to the PRF (SSN and shoulder joint) and ICI treatment groups (n = 10 in each). Primary outcome is hemiplegic shoulder pain severity, measured by numeric rating scale, active shoulder range of motion and Fugl-Meyer upper limb assessment. Secondary outcome is shoulder joint and cervicocephalic kinesthetic sensibility. Outcome measurements were assessed at baseline and one, two and six months after each procedure.

Timeline

Start
2022-04-01
Primary completion
2024-01-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 40 mg Other
Comparator Lidocaine Other / unclassified 1 ml Other
Comparator Lidocaine Other / unclassified 10 % Other